Paper42137125
Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients.
TajikRostami F and 5 others. Gastroenterol Hepatol Bed Bench, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients. Papers, record 42137125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42137125
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of complete and incomplete response to neoadjuvant therapy in rectum cancer patients.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11279603 | Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11279603 | PubMed |
| 2 | 39003454 | Key genes and molecular mechanisms related to Paclitaxel Resistance. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39003454 | PubMed |
| 3 | 38433568 | Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight. | Phytother Res | 2024 | https://conductscience.org/library/papers/38433568 | PubMed |
| 4 | 23634254 | CDK4: A Key Player in the Cell Cycle, Development, and Cancer. | Genes Cancer | 2012 | https://conductscience.org/library/papers/23634254 | PubMed |
| 5 | 15142631 | Review of epidermal growth factor receptor biology. | Int J Radiat Oncol Biol Phys | 2004 | https://conductscience.org/library/papers/15142631 | PubMed |
| 6 | 20140529 | Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. | Ann Surg Oncol | 2010 | https://conductscience.org/library/papers/20140529 | PubMed |
| 7 | 39757310 | Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer. | Mol Biomed | 2025 | https://conductscience.org/library/papers/39757310 | PubMed |
| 8 | 26328044 | Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer. | Gastroenterol Hepatol Bed Bench | 2015 | https://conductscience.org/library/papers/26328044 | PubMed |
| 9 | 37793085 | MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors. | J Clin Oncol | 2024 | https://conductscience.org/library/papers/37793085 | PubMed |
| 10 | 34208601 | Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34208601 | PubMed |
| 11 | 37527040 | FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth. | Cell Rep | 2023 | https://conductscience.org/library/papers/37527040 | PubMed |
| 12 | 10874008 | Expression of Jun family members in human colorectal adenocarcinoma. | Carcinogenesis | 2000 | https://conductscience.org/library/papers/10874008 | PubMed |
| 13 | 39000238 | Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000238 | PubMed |
| 14 | 31191840 | Gene screening of colorectal cancers via network analysis. | Gastroenterol Hepatol Bed Bench | 2019 | https://conductscience.org/library/papers/31191840 | PubMed |
| 15 | 29045232 | Imaging Neoadjuvant Therapy Response in Breast Cancer. | Radiology | 2017 | https://conductscience.org/library/papers/29045232 | PubMed |
| 16 | 23331916 | The origins of multicellular organisms. | Evol Dev | 2013 | https://conductscience.org/library/papers/23331916 | PubMed |
| 17 | 38918650 | Diagnostic and Prognostic Value of miR-451 Expression in Colorectal Cancer: A Meta-Analysis. | Asian Pac J Cancer Prev | 2024 | https://conductscience.org/library/papers/38918650 | PubMed |
| 18 | 36879254 | Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. | J Transl Med | 2023 | https://conductscience.org/library/papers/36879254 | PubMed |
| 19 | 35197754 | Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer. | Saudi J Biol Sci | 2022 | https://conductscience.org/library/papers/35197754 | PubMed |
| 20 | 35970919 | Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer. | Nat Med | 2022 | https://conductscience.org/library/papers/35970919 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| GNRH1 | 2796 | PubTator's text mining | https://conductscience.org/library/genes/2796 | NCBI Gene |
| IGF1 | 3479 | PubTator's text mining | https://conductscience.org/library/genes/3479 | NCBI Gene |
| JUN | 3725 | PubTator's text mining | https://conductscience.org/library/genes/3725 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42137125
GET https://conductscience.org/api/papers/v1/42137125/references?page=2